In an integrative analysis, we combined the available data of recurrent mutations, SCNAs, and structural variants affecting BCL2 and BCL6 in order to attribute each EBV + DLBCL sample to one of the defined molecular DLBCL clusters A53, N1, BN2, EZB, and MCD applying the LymphGen 2.0 classifier [25, 26]. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.